108P - Treatment compliance, tolerance and efficacy in elderly patients with advanced non-small cell lung cancer receiving first line chemotherapy: a compa...

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Pharmacology
Geriatric Oncology
Non-Small-Cell Lung Cancer, Metastatic
Presenter Giannis Mountzios
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors G. Mountzios1, M. Bakogeorgos2, E. Mpournakis2, P. Economopoulou1, N. Kentepozidis1, M.A. Dimopoulos2
  • 1Medical Oncology, 251 Airforce General Hopsital, 11525 - Athens/GR
  • 2Medical Oncology, University of Athens School of Medicine, Athens/GR


Elderly patients with advanced non-small cell lung cancer (NSCLC) tend to receive suboptimal treatment mainly due to fears of poor compliance and excessive toxicity.